Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce C Carleton

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 8, 2025
Systematic Review and Meta-Analysis: Acetaminophen Use During Pregnancy and the Risk of Neurodevelopmental Disorders in ChildhoodAnick Bérard, Judith Cottin, Lisiane F Leal, et al.
Nature Genetics|July 18, 2018
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosisKaarina Kowalec, Galen E B Wright, Britt I Drögemöller, et al.
JAMA Oncology|April 28, 2017
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerBritt I Drögemöller, Jose G Monzon, Amit P Bhavsar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2022
Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis CCatrina M Loucks, Jennifer J Lin, Jessica N Trueman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 12, 2022
A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant womenBritt I Drögemöller, Galen E B Wright, Jessica Trueman, et al.
JMIR Research Protocols|March 20, 2019
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE StudyEva Clemens, Annelot Jm Meijer, Linda Broer, et al.
JAMA Oncology|August 12, 2021
Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus ReportAnnelot J M Meijer, Marry M van den Heuvel-Eibrink, Beth Brooks, et al.
Journal of Personalized Medicine|November 27, 2021
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation StudyZulfan Zazuli, Corine de Jong, Wei Xu, et al.
Pediatric Blood & Cancer|March 27, 2026
Novel Genetic Risk Factor Identified for L-Asparaginase-Induced Pancreatitis in Pediatric Patients With CancerEdward J Raack, Wan-Chun Chang, Miguel Cordova-Delgado, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2011
Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in childrenHenk Visscher, Colin J D Ross, S Rod Rassekh, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 8, 2025
Systematic Review and Meta-Analysis: Acetaminophen Use During Pregnancy and the Risk of Neurodevelopmental Disorders in ChildhoodAnick Bérard, Judith Cottin, Lisiane F Leal, et al.
Nature Genetics|July 18, 2018
Common variation near IRF6 is associated with IFN-β-induced liver injury in multiple sclerosisKaarina Kowalec, Galen E B Wright, Britt I Drögemöller, et al.
JAMA Oncology|April 28, 2017
Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerBritt I Drögemöller, Jose G Monzon, Amit P Bhavsar, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 2, 2022
Patient-specific genetic factors predict treatment failure in sofosbuvir-treated patients with chronic hepatitis CCatrina M Loucks, Jennifer J Lin, Jessica N Trueman, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 12, 2022
A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant womenBritt I Drögemöller, Galen E B Wright, Jessica Trueman, et al.
JMIR Research Protocols|March 20, 2019
Genetic Determinants of Ototoxicity During and After Childhood Cancer Treatment: Protocol for the PanCareLIFE StudyEva Clemens, Annelot Jm Meijer, Linda Broer, et al.
JAMA Oncology|August 12, 2021
Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus ReportAnnelot J M Meijer, Marry M van den Heuvel-Eibrink, Beth Brooks, et al.
Journal of Personalized Medicine|November 27, 2021
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation StudyZulfan Zazuli, Corine de Jong, Wei Xu, et al.
Pediatric Blood & Cancer|March 27, 2026
Novel Genetic Risk Factor Identified for L-Asparaginase-Induced Pancreatitis in Pediatric Patients With CancerEdward J Raack, Wan-Chun Chang, Miguel Cordova-Delgado, et al.
Pageof 14